Emerging Approaches to Food Desensitization in Children.

about

Nutrition and Allergic Diseases.Allergen immunotherapy for birch-apple syndrome: what do we know?

P2860

Q42340601-52F5BC6A-94A7-4A21-AD56-F203D2506896 Q47410397-9483A0A7-F26E-4B10-91FA-79224A4FF138

P2860

Emerging Approaches to Food Desensitization in Children.

Item

http://www.wikidata.org/entity/Q38692435

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Emerging Approaches to Food Desensitization in Children.

@en

type

Item

label

Emerging Approaches to Food Desensitization in Children.

@en

prefLabel

Emerging Approaches to Food Desensitization in Children.

@en

P1476

Emerging Approaches to Food Desensitization in Children.

@en

P2093

Ahmad Hamad

http://www.w3.org/2001/XMLSchema#string

Wesley A Burks

http://www.w3.org/2001/XMLSchema#string

P2860

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

The Prevalence and Natural History of Food Allergy.

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.

National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006.

Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.

Two year effects of food allergen immunotherapy on quality of life in caregivers of children with food allergies

A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy

Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.

Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy.

P2888

s11882-017-0700-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11882-017-0700-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084978669

http://www.w3.org/2001/XMLSchema#string

P698

28429307

http://www.w3.org/2001/XMLSchema#string

Emerging Approaches to Food Desensitization in Children.

about

P2860

P2860

Emerging Approaches to Food Desensitization in Children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698